567
Participants
Start Date
November 30, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
August 31, 2009
Varenicline
According to the approved Summary of Product Characteristics (SmPC), patients will be required to orally take 0.5 mg once daily for the first 3 days and titrate up to 0.5 mg twice daily for days 4 - 7. From day 8 to the end of treatment patients should take 1 mg twice daily. Patients who cannot tolerate adverse effects of Champix may have the dose lowered temporarily or permanently to 0.5 mg twice daily. Patients should be treated for 12 weeks. Treatment should start 1 - 2 weeks prior to quitting smoking.
Pfizer Investigational Site, Ljubljana
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Jette
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Domžale
Pfizer Investigational Site, Cerknica
Pfizer Investigational Site, Vilvoorde
Pfizer Investigational Site, Maribor
Pfizer Investigational Site, Érd
Pfizer Investigational Site, Rijkevorsel
Pfizer Investigational Site, Beerse
Pfizer Investigational Site, Edegem
Pfizer Investigational Site, Leuven
Pfizer Investigational Site, Hatvan
Pfizer Investigational Site, Eger
Pfizer Investigational Site, Halen
Pfizer Investigational Site, Genk
Pfizer Investigational Site, Kortessem
Pfizer Investigational Site, Liège
Pfizer Investigational Site, Kranj
Pfizer Investigational Site, Jesenice
Pfizer Investigational Site, Nyíregyháza
Pfizer Investigational Site, Alleur
Pfizer Investigational Site, Namur
Pfizer Investigational Site, Vedrin
Pfizer Investigational Site, Monceau-sur-Sambre
Pfizer Investigational Site, Habay-la-Neuve
Pfizer Investigational Site, Libramont-Chevigny
Pfizer Investigational Site, Braine-le-Comte
Pfizer Investigational Site, Zedelgem
Pfizer Investigational Site, Moerkerke
Pfizer Investigational Site, Farkasgyepű
Pfizer Investigational Site, Siófok
Pfizer Investigational Site, Zalaegerszeg
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Moorsel
Pfizer Investigational Site, Szombathely
Pfizer Investigational Site, Deinze
Pfizer Investigational Site, Cholargós
Pfizer Investigational Site, Ilisia
Pfizer Investigational Site, Marousi
Pfizer Investigational Site, Ioannina
Pfizer Investigational Site, Thessaloniki
Pfizer Investigational Site, Eksochi
Pfizer Investigational Site, Kavala
Pfizer Investigational Site, Alexandroupoli
Pfizer Investigational Site, Heraklion
Pfizer Investigational Site, Yvoir
Pfizer Investigational Site, Larissa
Lead Sponsor
Pfizer
INDUSTRY